PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28962480-1	2015	This study was designed to evaluate whether glycogen synthase kinase-3beta (GSK-3beta) inhibitor, 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8) induced the the expression of connexin 43 (Cx43) to protect against renal ischemia-reperfusion (I/R) injury (RI/RI) in rats.	4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione	98-147	gap junction protein, alpha 1	Rattus norvegicus	187-198	
28962480-1	2015	This study was designed to evaluate whether glycogen synthase kinase-3beta (GSK-3beta) inhibitor, 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8) induced the the expression of connexin 43 (Cx43) to protect against renal ischemia-reperfusion (I/R) injury (RI/RI) in rats.	4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione	98-147	gap junction protein, alpha 1	Rattus norvegicus	200-204	
28962480-3	2015	The results indicated that TDZD-8 improved the recovery of renal function, reduced oxidative stress and inflammation injury, and upregulated the expression of (Cx43) as compared to I/R group.	4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione	27-33	gap junction protein, alpha 1	Rattus norvegicus	160-164	
28962480-4	2015	Therefore, our study demonstrated that TDZD-8 provided a protection to the kidney against I/R injury in rats through inducing the expression of (Cx43).	4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione	39-45	gap junction protein, alpha 1	Rattus norvegicus	145-149